R&D Green shoots and cautious optimism: Insights from BIO-Europe... With thousands of pharma and biotech dealmakers attending last months’ BIO-Europe Spring, appetite for partnering looked alive and well.
R&D BIO-Europe Spring 2023, Basel, Switzerland – Part One Travelling to Basel, Switzerland for Informa Connect / EBD Group’s BIO-Europe Spring, taking place at the Messe Congress Center between the 20th and 22nd March, pharmaphorum listened to par
Digital BIO-Europe Spring Digital: Big data and AI panel discussion The combination of big data and artificial intelligence/machine learning is a powerful one and nowhere more so than in healthcare.
Videos BIO-Europe Spring Digital: Nerida Scott, J&J’s EMEA Innovati... At this year’s BIO-Europe Spring Digital, pharmaphorum founder Dr.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends